Shikonin protects mitochondria through the NFAT5/AMPK pathway for the treatment of diabetic wounds

Figure 5 Impact of NFAT5 and AMPK inhibitors on reactive oxygen species and protein expression in the NFAT5/AMPK pathway. A: Effect of NFAT5 and AMPK inhibitors on the fluorescence expression of reactive oxygen species; B: The expressions of protein (mTOR, Akt, p-Akt, NF-KB, VEGF, iNOS, Glut-1) via NFAT5/AMPK pathway. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001.